Every time it goes, it must be known (noon version) 丨 three major indexes have fallen slightly, and tourism and car stocks are active; medical stocks have fallen severe, beautiful and East China Medicine's latest response

At 11:30 on September 19th, Beijing time, the Shanghai Stock Exchange Index fell 4.94 points in the early early trading, a decrease of 0.16%, and closed at 3121.46 points, with a turnover of 188.134 billion yuan. The turnover was 247.706 billion yuan; the GEM finger fell 11.62 points, a decrease of 0.49%, the close of 2355.78 points, and the turnover of 83.27 billion yuan; the CSI 300 rose 5.53 points, the increase of 0.14%, the close 3938.21 points, the turnover 1178.988888, the turnover 1178.9888 100 million yuan.

Individual stocks fell more, and more than 3,600 stocks in the two cities fell. The half -day turnover of the Shanghai and Shenzhen cities reached 435.8 billion, a shrinkage of 33.1 billion in the morning from the previous trading day. In terms of funds in the north, the net inflow of the Shanghai Stock Connect in early trading was 1.035 billion, and the net inflow of Shenzhen Stock Connect was 140 million.

On the market, the vehicle stocks were stronger, and the Asian passenger cars rose up to 8%. The tourism sector performed active and Guilin's daily limit. Drinks, beer and other sectors rose, and Bairun, Lanzhou Yellow River, Huiquan Beer daily limit. The overall market hotspot is more messy and limited. In terms of decline, the lively software stocks that were active on Friday were collectively adjusted.

The concept of medical beauty fell sharply on the 19th. As of the afternoon, Huaxi creatures fell more than 10%, and the session fell nearly 11%. Ai Meimei fell more than 9%, and the session fell 12%. In addition, Fuji, Langzi, and Guangzheng Ophthalmology all fell more than 6%.

According to the Securities Times, for the sharp fluctuation of the stock price today, the insiders of the beauty guest responded that the company's operations have not changed. The person believes that the strict supervision of the medical beauty industry will guide and standardize the healthy and orderly development of the industry. The industry's midstream head enterprises and the current standardized medical cosmetic institutions will get more market opportunities, which is conducive to accelerating the industry's clearing. Promote the high -quality development of the medical beauty industry.

The first five industries were 2.54%of the vehicles, 1.98%of tourist hotels, 1.89%of the brewing industry, 1.5%of energy metal, and 1.08%of aviation airports.

The first five industries of the decline are the game -2.78%, the Internet service -2.72%, the beauty care-2.71%, the software development -2.48%, and the aerospace-2.33%.

In the early morning of September 19, the main funds were inflow into cars, liquor, coal, tourism and other sectors, and net outflow of medical beauty, securities firms, power, military industry and other sectors.

In terms of individual stocks, Guizhou Moutai rose nearly 1%, and won the top 694 million yuan in the main force; Nantian Information and Selis received the main force of 621 million yuan and 591 million yuan respectively; During the Ningde era, BYD, etc., the main net inflow of the main force was high.

In terms of net outflow, Aofei Entertainment fell in the morning, and was under the main net outflow of 237 million yuan; Qingdao Golden King, Tianhua Chaojing, Shengtong Energy, Yongtai Energy, Hailian Jinhui, and Guangfa Securities were all sold over 100 million yuan.

Dolute (SZ300950, the stock price of 22.05 yuan, a market value of 3.308 billion yuan) announced on the afternoon of September 19th, Wei Feng, a shareholder with a total of 3.75%of the company, and Shanghai Qingwang Entrepreneurship Investment Partnership (Limited Partnership) The total transaction method reduces the company's shares of not over 5.625 million shares (accounting for 3.75%of the company's total share capital).

Longjin Pharmaceutical (SZ002750, stock price of 9.87 yuan, market value of 3.753 billion yuan) announced on the afternoon of September 19th, and the holding subsidiary Yunnan Zhongke Longjin Biotechnology Co., Ltd. "ZKLJ02" was notified of the drug clinical trial approval notice. The drug is suitable for acute ischemia strokes and improves neurological defects.

Yipinhong (SZ300723, the stock price of 22.73 yuan, a market value of 6.531 billion yuan) announced on the afternoon of September 19th, and the all -funded subsidiary was approved for approval from the application for supplementary applications for amroar hydrochloride drugs, marking the company's sales of drugs in the domestic market. The qualifications will further enrich the pipelines and categories of children's medicine products.

East China Pharmaceutical (SZ00963, the stock price of 39.83 yuan, and a market value of 69.69 billion yuan) told reporters that the company's production and operation is normal, and it has paid attention to some online information. The company has one or two medical institutions. Operating in Hangzhou, the company's domestic medical cosmetic products are only Yi Yanshi. Today, the concept of medical beauty in the morning has plummeted, and East China Pharmaceutical's closure of 5.21%as of the closing of the morning. (Financial Association)

Daily Economic News

- END -